ImmuniWeb® named most advanced hybrid on-demand web penetration testing SaaSMarch 17, 2015
Frost & Sullivan publishes new Market Insight identifying hybrid web application security testing SaaS, led by ImmuniWeb®, as an emerging growth market.
Frost & Sullivan’s new Market Insight, entitled “The Rise of Hybrid Web Application Security Testing”, has identified the growing need for businesses of all sizes to have a web application security testing solution that blends the efficiency of automated scanning with the effectiveness of a manual penetration testing.
The Market Insight identifies the cost effectiveness of such hybrid solutions as, for most businesses, an automated vulnerability scanning is not comprehensive enough, while manual web application penetration testing is either too expensive or simply too infrequent to provide the necessary security insight to identify risks before they arise.
SaaS Hybrid Application Security Assessment Characteristics (c) Frost & Sullivan
The security sector Market Insight highlights the need for defined web application security practices, and also investigates the challenges facing traditional web security models.
The Market Insight concludes that the emergence of hybrid security assessment solutions delivered as a SaaS model are an innovative, efficient and much-need approach for businesses:
“A true hybrid solution should integrate feedback from manual penetration tests to develop the automated technology further, while automated scanning gives more and more useful information to the (manual) auditors…….This creates a virtuous circle of product development that improves the accuracy of the automated test as well as each subsequent test. As a result, the value created by a hybrid web application security assessment is greater than the sum of its automated and manual testing components.”
“Combining the efficiency of automated testing and effectiveness of manual penetration testing in a hybrid solution and enabling these through a SaaS delivery model is a logical move toward achieving the greatest possible security from a limited budget.”
The Market Insight gives particular recognition to High-Tech Bridge’s on-demand web application penetration testing SaaS ImmuniWeb:
“ImmuniWeb on-demand web penetration testing solution is a good example of a hybrid testing SaaS based on its proprietary ImmuniWeb scanner, which is used and supported by internal penetration testing experts and can be configured and managed through an online portal. Of the solutions tracked as part of this research, High-Tech Bridge offers the most complete hybrid-labelled offering available today, having realized the importance of a hybrid approach and having the SaaS model needed to facilitate integration of manual penetration testing expertise into its proprietary scanning technology.”
Ilia Kolochenko, High-Tech Bridge’s CEO and the chief architect of ImmuniWeb platform, comments: “Our company is honoured to be recognized by Frost & Sullivan as the leader of this emerging market. The independent Market Insight confirms that our efforts and strategy align with market requirements. Currently we are developing our ImmuniWeb partnership program that enables a range of companies to add value to their businesses by adding our award-winning solution into their portfolios.”
Mr. Marsel Nizamutdinov, High-Tech Bridge’s Chief Research Officer, adds: “Customer satisfaction is a key priority; this is why we have a continuous improvement program in place. Thanks to our unique hybrid model, we are able to use daily feedback from our penetration testers to improve the ImmuniWeb service.”
ImmuniWeb has also been recently selected as a finalist in the Info Security Products Guide 2015 Global Excellence Awards. The industry's leading information security awards panel has selected ImmuniWeb as a finalist in Vulnerability Assessment, Remediation and Management category, among such products as Nessus, Tripwire IP360, and Retina CS Enterprise Vulnerability Management. The 11th Annual 2015 Global Excellence Awards ceremony will take place on the 20th of April in San Francisco.